SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-24-284312 from Acadia Healthcare Company, Inc. (ACHC) (CIK 0001520697) (ACHC)

Acadia Healthcare Company, Inc. (ACHC) (CIK 0001520697)
Date: Dec. 23, 2024 · CIK: 0001520697 · Accession: 0001193125-24-284312

AI Filing Summary & Sentiment

File numbers found in text: 001-35331

Date
December 23, 2024
Author
Not clearly detected
Form
CORRESP
Company
Acadia Healthcare Company, Inc. (ACHC) (CIK 0001520697)

Letter

December 23, 2024

VIA EDGAR

Tayyaba Shafique

Tracey Houser

Division of Corporation Finance

Office of Industrial Applications and Services

United States Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Re: Acadia Healthcare Company, Inc.

Form 10-K for Fiscal Year Ended December 31, 2023

Form 8-K Filed February 27, 2024

Response dated December 6, 2024

File No. 001-35331

Ladies and Gentlemen:

On behalf of Acadia Healthcare Company, Inc. (the “Company”), we acknowledge receipt of your letter (the “Comment Letter”), dated December 20, 2024, with respect to the Company’s Form 8-K, filed on February 27, 2024 (File No. 001-35331), in which you requested that we respond within ten business days or advise you when we would provide a response. We have begun to analyze the comments of the staff of the U.S. Securities and Exchange Commission and the Company is in the process of preparing a response. We respectfully request an extension of five business days so that we may devote the appropriate amount of time and resources to ensure a sufficient response. The Company will provide a comprehensive response to the Comment Letter no later than January 15, 2025.

We appreciate your consideration in this matter. If you have any questions concerning our request, please contact Matthew Pacey of Kirkland & Ellis LLP at (713) 836-3786 or Heather Dixon of the Company at (615) 861-7307.

[Signature Page Follows]

Very truly yours,
ACADIA HEALTHCARE COMPANY, INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 December 23, 2024

VIA EDGAR

 Tayyaba Shafique

Tracey Houser

 Division of Corporation Finance

Office of Industrial Applications and Services

 United States
Securities and Exchange Commission

 100 F Street, NE

Washington, D.C. 20549

Re:
 Acadia Healthcare Company, Inc.

Form 10-K for Fiscal Year Ended December 31, 2023

Form 8-K Filed February 27, 2024

Response dated December 6, 2024

File No. 001-35331

Ladies and Gentlemen:

 On behalf of Acadia
Healthcare Company, Inc. (the “Company”), we acknowledge receipt of your letter (the “Comment Letter”), dated December 20, 2024, with respect to the Company’s Form 8-K, filed on February 27, 2024 (File No. 001-35331), in which you requested that we respond within ten business days or advise you when we would provide a response.
We have begun to analyze the comments of the staff of the U.S. Securities and Exchange Commission and the Company is in the process of preparing a response. We respectfully request an extension of five business days so that we may devote the
appropriate amount of time and resources to ensure a sufficient response. The Company will provide a comprehensive response to the Comment Letter no later than January 15, 2025.

We appreciate your consideration in this matter. If you have any questions concerning our request, please contact Matthew Pacey of
Kirkland & Ellis LLP at (713) 836-3786 or Heather Dixon of the Company at (615) 861-7307.

[Signature Page Follows]

Very truly yours,

ACADIA HEALTHCARE COMPANY, INC.

 /s/ Heather Dixon

Name:

Heather Dixon

Title:

Chief Financial Officer

cc:
 Christopher H. Hunter, Acadia Healthcare Company, Inc.

Brian Farley, Acadia Healthcare Company, Inc.

Matthew R. Pacey, P.C., Kirkland & Ellis LLP

Ieuan A. List, Kirkland & Ellis LLP